Nicotine

Effects

Overview

Nicotine is a naturally-occurring alkaloid which can have both stimulant and depressant effects due to it affecting a range of biological systems simultaneously.[1] PW

A chemical found in tobacco, aubergines and tomatoes which is considered one of the most addictive drugs in existence. It is a mild stimulant, with stress relieving effects. It is widely used in the form of cigarettes, the use of which carries a high risk of causing cancer or heart issues over time. Increasingly, it is 'vaped' as a purportedly safer alternative to smoking.[2–8] TS

Nicotine is a stimulant and alkaloid found primarily in plants of the nightshade family, notably in tobacco; it is also synthesized. Nicotine is used recreationally for its stimulant and anxiolytic effects. In tobacco leaves, nicotine constitutes about 0.6–3% of the dry weight, and smaller, trace quantities occur in other Solanaceae crops such as tomatoes, potatoes, and eggplants. In pure form, nicotine is a colorless to yellowish, oily liquid that readily penetrates biological membranes and acts as a potent neurotoxin in insects, where it serves as an antiherbivore toxin. Historically, it was widely used as an insecticide, and its structure provided the basis for synthetic neonicotinoid pesticides.[9][10][11] WP

In humans, nicotine acts primarily as a stimulant by binding to and activating nicotinic acetylcholine receptors (nAChRs) in the central nervous system and peripheral tissues. This results in the release of neurotransmitters such as dopamine, acetylcholine, and norepinephrine, producing effects including increased alertness, reduced anxiety, and mild euphoria. Nicotine is typically consumed through tobacco smoking, vaping, or other nicotine delivery systems. An average cigarette yields about 2 mg of absorbed nicotine, a dose sufficient to produce reinforcement and dependence while remaining far below toxic levels.[12][13] WP

Nicotine is highly addictive, and nicotine dependence is characterized by tolerance, physical dependence, psychological dependence, and nicotine withdrawal symptoms such as irritability, anxiety, and difficulty concentrating. Nicotine replacement therapy (NRT) products, including gums, patches, and lozenges, deliver the compound in slower, lower doses that are less addictive and are used medically to help people quit smoking. Synthetic derivatives of nicotine, such as varenicline, act as partial agonists at nicotinic receptors and are also used as smoking cessation aids.[14–18] WP

Nicotine itself is not classified as a carcinogen by either the International Agency for Research on Cancer or the Surgeon General of the United States. At high doses it can cause nicotine poisoning and respiratory paralysis. Nicotine is also a known teratogen, associated with adverse developmental effects during pregnancy, and may impair adolescent neurodevelopment, though the extent of this effect in humans remains debated.[19][20][21] WP

History

History

Nicotine was originally isolated from the tobacco plant in 1828 by chemists Wilhelm Heinrich Posselt and Karl Ludwig Reimann from Germany, who believed it was a poison. Its chemical empirical formula was described by Melsens in 1843, its structure was discovered by Adolf Pinner and Richard Wolffenstein in 1893, and it was first synthesized by Amé Pictet and A. Rotschy in 1904.[24–31] WP⚠ Wikipedia itself has flagged this text: clarification needed.

Nicotine is named after the tobacco plant Nicotiana tabacum, which in turn is named after the French ambassador in Portugal, Jean Nicot de Villemain, who sent tobacco and seeds to Paris in 1560, presented to the French King, and who promoted their medicinal use. Smoking was believed to protect against illness, particularly the plague. However, the "holy herb", tobacco, had first reached Europe by the early 1530s, brought by Spanish explorers.[32][33] WP

Following its introduction, tobacco rapidly gained popularity in Europe for its stimulating effects, fueled by nicotine's addictive and pharmacological properties and tobacco's widespread embrace as a cure-all. By the early 17th century, this allure fueled its mercilessly laborious cultivation as a cash crop in the Virginia colonies, where John Rolfe's introduction in 1612 rescued Jamestown from economic collapse and famine, transforming it into a prosperous export hub with over 20,000 pounds shipped by 1619 and laying the groundwork for transatlantic trade. From the 17th century onward, tobacco smoking became virtually central to European social, economic, and cultural history and beyond, entrenching itself in daily rituals, trade networks, and even international conflicts.[34] WP

By the late 17th century, tobacco was used not only for smoking but also as an insecticide. After World War II, over 2,500 tons of nicotine insecticide were used worldwide, but by the 1980s the use of nicotine insecticide had declined below 200 tons. This was due to the availability of other insecticides that are cheaper and less harmful to mammals.[11] WP

The nicotine content of popular American-brand cigarettes has increased over time, and one study found that there was an average increase of 1.78% per year between the years of 1998 and 2005.[35] WP

Although methods of production of synthetic nicotine have existed for decades, it was believed that the cost of making nicotine by laboratory synthesis was cost prohibitive compared to extracting nicotine from tobacco. However, recently synthetic nicotine started to be found in different brands of e-cigarettes and oral pouches and marketed as "tobacco-free".[36][37] WP

Legal status

• Nicotine is legal nearly all over the world and is one of the most popularly used substances. The sale of tobacco products are usually restricted to adults, and they are often heavily taxed. PW
• Australia: From 1 October 2021, Nicotine in salt or freebase forms (including solutions) are illegal to import into the country without a license and permit. This also includes refillable nicotine pods and any vape products containing nicotine.[38] PW
• Bhutan: Tobacco products are legal, but their public use is restricted to specific smoke-friendly areas.[39] PW

Regulation

In the United States, the Food and Drug Administration (FDA) regulates nicotine as a tobacco product under the 2009 Family Smoking Prevention and Tobacco Control Act. The FDA is tasked with reviewing tobacco products such as e-cigarettes and determining which can be authorized for sale.[40] WP

In March 2022, the US Congress passed a law (the Consolidated Appropriations Act, 2022) that expanded FDA's tobacco regulatory authority to include tobacco products containing nicotine from any source, thereby including products made with synthetic nicotine.[40] WP

On January 17, 2025, the FDA proposed a strongly endorsed rule to reduce nicotine in cigarettes and certain combusted tobacco products to minimally or non-addictive levels, capping nicotine yield at 0.7 mg per gram of tobacco, approximately a 95% reduction from current commercial levels.[41][42] WP

In the European Union, the Tobacco Products Directive (2014/40/EU) regulates the manufacture, presentation, and sale of tobacco and related products.[43] WP

In the United Kingdom, the Tobacco and Related Products Regulations 2016 implemented the European directive 2014/40/EU, amended by Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 and the Tobacco Products and Nicotine Inhaling Products (Amendment) (EU Exit) Regulations 2020. Additionally other regulations limit advertising, sale and display of tobacco products and other products containing nicotine for human consumption. The Sunak government proposed banning disposable vapes to limit their appeal and affordability for children and to reduce the amount of waste generated. WP

Age limits on purchase

In the United States, over-the-counter nicotine replacement therapy products are only available to people aged 18 and above, and it is not for sale in vending machines or from any source where proof of age cannot be verified. The minimum age to purchase tobacco products in the US is 21 at the federal level.[44] WP

In the European Union, the minimum age to purchase nicotine products is 18 in all member states except Latvia, where it is 20. However, there is no minimum age requirement to use tobacco or nicotine products.[45][46] WP

In the United Kingdom, the minimum age to purchase tobacco products is 18.[47] WP

In media

The public's lack of understanding regarding nicotine's biological effects frequently results in inaccurate claims disseminated by the media and general public.[48] WP

In some anti-smoking literature, the harm that tobacco smoking and nicotine addiction does is personified as Nick O'Teen, represented as a humanoid with some aspect of a cigarette or cigarette butt about him or his clothes and hat. Nick O'Teen was a villain that was created for the Health Education Council. The character was featured in three animated anti-smoking public service announcements in which he tries to get kids addicted to cigarettes before being foiled by the DC Comics character Superman.[49] WP

Nicotine was often compared to caffeine in advertisements in the 1980s by the tobacco industry, and later in the 2010s by the electronic cigarettes industry, in an effort to reduce the stigmatization and the public perception of the risks associated with nicotine use.[50] WP

Pharmacology

Pharmacodynamics

Nicotine acts as a receptor agonist at most nicotinic acetylcholine receptors (nAChRs), except at two nicotinic receptor subunits (nAChRα9 and nAChRα10) where it acts as a receptor antagonist. Such antagonism results in mild analgesia.[51][52][53] WP

The stereochemistry of nicotine is crucial to its biological effects. Due to the chiral nature of its receptors in the body, the (S)-enantiomer is substantially more active. For this reason, nearly all pharmacological and toxicological data is based on studies of (S)-nicotine. (S)-Nicotine is 4–28 times more potent than (R)-nicotine in standard nicotinic receptor binding and functional assays and elicits stronger nasal irritation, stinging, and mucosal responses at lower detection thresholds—yet smokers rated it as more pleasant in the only human sensory study. The pharmacological, metabolic, and toxicological effects of (R)-nicotine and of racemic (R)/(S)-nicotine mixtures in humans remain poorly understood, with data largely limited to animal studies.[54][55] WP

Sympathetic nervous system

Nicotine also activates the sympathetic nervous system, acting via splanchnic nerves to the adrenal medulla, stimulating the release of epinephrine. Acetylcholine released by preganglionic sympathetic fibers of these nerves acts on nicotinic acetylcholine receptors, causing the release of epinephrine (and norepinephrine) into the bloodstream.[56] WP⚠ Wikipedia itself has flagged this text: citation needed.

Adrenal medulla

By binding to ganglion type nicotinic receptors in the adrenal medulla, nicotine increases flow of adrenaline (epinephrine), a stimulating hormone and neurotransmitter. By binding to the receptors, it causes cell depolarization and an influx of calcium through voltage-gated calcium channels. Calcium triggers the exocytosis of chromaffin granules and thus the release of epinephrine (and norepinephrine) into the bloodstream. The release of epinephrine (adrenaline) causes an increase in heart rate, blood pressure and respiration, as well as higher blood glucose levels.[57] WP

Pharmacokinetics

As nicotine enters the body, it is distributed quickly through the bloodstream and crosses the blood–brain barrier reaching the brain within 10–20 seconds after inhalation. The elimination half-life of nicotine in the body is around two hours. Nicotine is primarily excreted in urine and urinary concentrations vary depending upon urine flow rate and urine pH.[58–61] WP

The amount of nicotine absorbed by the body from smoking can depend on many factors, including the types of tobacco, whether the smoke is inhaled, and whether a filter is used. However, it has been found that the nicotine yield of individual products has only a small effect (4.4%) on the blood concentration of nicotine, suggesting "the assumed health advantage of switching to lower-tar and lower-nicotine cigarettes may be largely offset by the tendency of smokers to compensate by increasing inhalation".[62] WP

Cotinine is an active metabolite of nicotine that remains in the blood with a half-life of 18–20 hours, making it easier to analyze due to longer half-life than that of nicotine itself.[63] WP

Nicotine is metabolized in the liver by cytochrome P450 enzymes (mostly CYP2A6, and also by CYP2B6) and FMO3, which selectively metabolizes (S)-nicotine. A major metabolite is cotinine. Other primary metabolites include nicotine N-oxide, nornicotine, nicotine isomethonium ion, 2-hydroxynicotine and nicotine glucuronide. Under some conditions, other substances may be formed such as myosmine.[64][65][66] WP

Glucuronidation and oxidative metabolism of nicotine to cotinine are both inhibited by menthol, an additive to mentholated cigarettes, thus increasing the half-life of nicotine in vivo.[67] WP

Influence of ionization state

Nicotine's absorption is modulated by its ionization state, governed by pH relative to pKa values (8.10 for pyrrolidine nitrogen, 3.41 for pyridine). At physiological pH (~7.4), it is mostly monoprotonated (cationic); above pH 8, it becomes unprotonated free-base, which is lipophilic and volatile. The distribution of nicotine among its free-base and protonated forms in aerosolised nicotine affects inhalability; it has been manipulated in tobacco smoke and now in electronic cigarettes by the use of acids to de-freebase nicotine and form 'nicotine salts'. Pod mod electronic cigarettes use nicotine in the form of a protonated nicotine, rather than free-base nicotine found in earlier generations.[68][69][70] WP

Free-base nicotine enables rapid membrane diffusion and higher bioavailability in early tobacco/oral studies. Yet, recent e-cigarette research contradicts this: protonated salts (e.g., nicotine benzoate, lactate, levulinate from acid addition) yield higher Cmax and faster onset than equivalent free-base. For example, 2% benzoate salt produced 3x higher Cmax in human puffing trials. Notably, Cmax of protonated nicotine salts appears independent of the composition and identity of the counter anions (e.g., benzoate, lactate, levulinate) forming the salts for higher administered nicotine formulations.[68][71] WP

These effects stem from aerosol dynamics—salts form low-volatility submicron particles for deeper lung deposition and less exhalation loss, versus free-base's superficial deposition. Sensorily, free-base delivers a harsh throat hit, while salts allow smoother high-dose inhalation, boosting appeal and intake.[68] WP

Metabolism

Nicotine decreases hunger and as a consequence food consumption, alongside increasing energy expenditure. The majority of research shows that nicotine reduces body weight, but some researchers have found that nicotine may result in weight gain under specific types of eating habits in animal models. Nicotine effect on weight appears to result from nicotine's stimulation of α3β4 nAChR receptors located in the POMC neurons in the arcuate nucleus and subsequently the melanocortin system, especially the melanocortin-4 receptors on second-order neurons in the paraventricular nucleus of the hypothalamus, thus modulating feeding inhibition. POMC neurons are a precursor of the melanocortin system, a critical regulator of body weight and peripheral tissue such as skin and hair.[72][73][74] WP

Detection in body fluids

Nicotine can be quantified in blood, plasma, or urine to confirm a diagnosis of poisoning or to facilitate a medicolegal death investigation. Urinary or salivary cotinine concentrations are frequently measured for the purposes of pre-employment and health insurance medical screening programs. Careful interpretation of results is important, since passive exposure to cigarette smoke can result in significant accumulation of nicotine, followed by the appearance of its metabolites in various body fluids. Nicotine use is not regulated in competitive sports programs.[75][76][77] WP

Optopharmacology

A photoactivatable form of nicotine, which releases nicotine when exposed to ultraviolet light with certain conditions, has been developed for studying nicotinic acetylcholine receptors in brain tissue.[78] WP

Chemistry

Formula

C10H14N2 PC

CAS number

54-11-5 PC

Molar mass (g/mol)

162.23 PC

IUPAC name (computed by PubChem)

3-[(2S)-1-methylpyrrolidin-2-yl]pyridine PC

SMILES

CN1CCC[C@H]1C2=CN=CC=C2 PC

InChIKey

SNICXCGAKADSCV-JTQLQIEISA-N PC

PubChem CID

89594

Pop culture

No references added yet.

References

1. Other Cholinergic Drugs I - Nicotinic and Muscarinic Receptors - Chemistry LibreTexts
2. Journal / agency Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial
3. Journal / agency Site of nicotine absorption from a vapour inhaler--comparison with cigarette smoking
4. Journal / agency Brand differences of free-base nicotine delivery in cigarette smoke: the view of the tobacco industry documents
5. Journal / agency Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity
6. Journal / agency Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection are there links?
7. Journal / agency Do electronic cigarettes impart a lower potential disease burden than conventional tobacco cigarettes? Review on E-cigarette vapor versus tobacco s
8. Journal / agency The impact of caffeine use on tobacco cessation and withdrawal
9. Journal / agency Fagerström K. Nicotine: Pharmacology, Toxicity and Therapeutic use. Journal of Smoking Cessation. December 2014. doi:10.1017/jsc.2014.27
10. Other Hoffmann D, Hoffmann I. Smoking and Tobacco Control Monograph No. 9. 1998
11. Journal / agency Ujváry I. Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor. 1999. doi:10.1007/978-4-431-67933-2_2
12. Journal / agency Sajja RK, Rahman S, Cucullo L. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress. Journal of Cerebral Blood Flow and Metabolism. March 2016. doi:10.1177/0271678X15616978 · PMID 26661236 · PMC4794105
13. Journal / agency Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives of Toxicology. January 2014. doi:10.1007/s00204-013-1127-0 · PMID 24091634 · PMC3880486
14. Journal / agency CDC. Health Effects of Vaping. 2025-01-31
15. Journal / agency Perkins KA, Karelitz JL. Reinforcement enhancing effects of nicotine via smoking. Psychopharmacology. August 2013. doi:10.1007/s00213-013-3054-4 · PMID 23494236 · PMC3707934
16. Other Nicotine: Clinical data
17. Journal / agency Etter JF. Addiction to the nicotine gum in never smokers. BMC Public Health. July 2007. doi:10.1186/1471-2458-7-159 · PMID 17640334 · PMC1939993
18. Journal / agency Coe JW et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry. May 2005. doi:10.1021/jm050069n · PMID 15887955
19. Journal / agency Lushniak BD, Samet JM, Pechacek TF, Norman LA, Taylor PA, National Center for Chronic Disease Prevention Health Promotion (US) Office on Smoking Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. 2014. PMID 24455788
20. Journal / agency Kohlmeier KA. Nicotine during pregnancy: changes induced in neurotransmission, which could heighten proclivity to addict and induce maladaptive control of attention. Journal of Developmental Origins of Health and Disease. June 2015. doi:10.1017/S2040174414000531 · PMID 25385318
21. Other U.S. Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. 2016
22. Journal / agency Seo, A. D., Kim, D. C., Yu, H. J., Kang, M. J. Accidental ingestion of E-cigarette liquid nicotine in a 15-month-old child: an infant mortality case of nicotine intoxication. Korean Journal of Pediatrics. December 2016. doi:10.3345/kjp.2016.59.12.490
23. Journal / agency Perkins, K. A. Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nicotine & Tobacco Research. 1 November 2002. doi:10.1080/1462220021000018425
24. Journal / agency Henningfield JE, Zeller M. Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward. Psychopharmacology. March 2006. doi:10.1007/s00213-006-0308-4 · PMID 16463054
25. Journal / agency Posselt W, Reimann L. Chemische Untersuchung des Tabaks und Darstellung eines eigenthümlich wirksamen Prinzips dieser Pflanze. Magazin für Pharmacie. 1828
26. Journal / agency Melsens LH. Note sur la nicotine. Annales de Chimie et de Physique. 1843
27. Journal / agency Pinner A, Wolffenstein R. Ueber Nicotin. Berichte der Deutschen Chemischen Gesellschaft. 1891. doi:10.1002/cber.189102401242
28. Journal / agency Pinner A. Ueber Nicotin. Die Constitution des Alkaloïds. Berichte der Deutschen Chemischen Gesellschaft. 1893. doi:10.1002/cber.18930260165
29. Journal / agency Pinner A. Ueber Nicotin. I. Mitteilung. Archiv der Pharmazie. 1893. doi:10.1002/ardp.18932310508
30. Journal / agency Pictet A, Rotschy A. Synthese des Nicotins. Berichte der Deutschen Chemischen Gesellschaft. 1904. doi:10.1002/cber.19040370206
31. Other Zhang S. E-Cigs Are Going Tobacco-Free With Synthetic Nicotine
32. Other Dale MM, Ritter JM, Fowler RJ, Rang HP. Rang & Dale's Pharmacology
33. Other Monardes N. Primera y segunda y tercera partes de la Historia medicinal de las cosas que se traen de nuestras Indias occidentales. 1580
34. Other Goodman J. Tobacco in History: The Cultures of Dependence. 2005
35. Journal / agency Connolly GN, Alpert HR, Wayne GF, Koh H. Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997-2005. Tobacco Control. October 2007. doi:10.1136/tc.2006.019695 · PMID 17897974 · PMC2598548
36. Other Industry Documents Library
37. Other Jewett C. The Loophole That's Fueling a Return to Teenage Vaping. 2022-03-08
38. Other TGA Vaping and Nicotine Import Ban
39. Journal / agency Tobacco Control Act of Bhutan, 2010 (in both Dzongkha and English), government of Bhutan. PDF file
40. Journal / agency Center for Tobacco Products. Family Smoking Prevention and Tobacco Control Act - An Overview. FDA. 2024-09-26
41. Journal / agency Commissioner, Office of the. FDA Proposes Significant Step Toward Reducing Nicotine to Minimally or Nonaddictive Level in Cigarettes and Certain Other Combusted Tobacco Products. 2025-01-15
42. Other AACR Expresses Support for FDA's Proposed Rule to Decrease Nicotine Content in Certain Combusted Tobacco Products
43. Other Product regulation - Public Health - European Commission. 2024-12-03
44. Journal / agency Products, Center for Tobacco. Tobacco 21. FDA. 2025-08-07
45. Other Smoking age limit to be raised to 20 as of 2025
46. Other 21, 18, or 14: A look at the legal age for smoking around the world. 3 October 2017
47. Other The Children and Young Persons (Sale of Tobacco etc.) Order 2007
48. Journal / agency Sinkevicius LV, Sakalauskaite S, Bukovskis M, Lõokene M, Valvere V, Gradauskiene B, Viigimaa M. Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective. International Journal of Molecular Sciences. July 2025. doi:10.3390/ijms26136437 · PMID 40650213 · PMC12250386
49. Journal / agency Jacob M. Superman versus Nick O'Teen — a children's anti-smoking campaign. Health Education Journal. 1 March 1985. doi:10.1177/001789698504400104
50. Other Becker R. Why Big Tobacco and Big Vape love comparing nicotine to caffeine. 26 April 2019
51. Other Nicotinic acetylcholine receptors: Introduction
52. Other Malenka RC, Nestler EJ, Hyman SE. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 2009
53. Journal / agency Kishioka S, Kiguchi N, Kobayashi Y, Saika F. Nicotine effects and the endogenous opioid system. Journal of Pharmacological Sciences. 2014. doi:10.1254/jphs.14R03CP · PMID 24882143
54. Journal / agency WHO study group on tobacco product regulation: report on the scientific basis of tobacco product regulation: ninth report of a WHO study group. 23 August 2023
55. Journal / agency Salam S, El-Hajj Moussa F, El-Hage R, El-Hellani A, Aoun Saliba N. A Systematic Review of Analytical Methods for the Separation of Nicotine Enantiomers and Evaluation of Nicotine Sources. Chemical Research in Toxicology. March 2023. doi:10.1021/acs.chemrestox.2c00310 · PMID 36897818 · PMC10031562
56. Journal / agency Yoshida T, Sakane N, Umekawa T, Kondo M. Effect of nicotine on sympathetic nervous system activity of mice subjected to immobilization stress. Physiology & Behavior. January 1994. doi:10.1016/0031-9384(94)90009-4 · PMID 8140174
57. Other Marieb EN, Hoehn K. Human Anatomy & Physiology (7th Ed.). 2007
58. Journal / agency Le Houezec J. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. The International Journal of Tuberculosis and Lung Disease. September 2003. PMID 12971663
59. Journal / agency Kolli AR, Calvino-Martin F, Kuczaj AK, Wong ET, Titz B, Xiang Y, Lebrun S, Schlage WK, Vanscheeuwijck P, Hoeng J. Deconvolution of Systemic Pharmacokinetics Predicts Inhaled Aerosol Dosimetry of Nicotine. European Journal of Pharmaceutical Sciences. January 2023. doi:10.1016/j.ejps.2022.106321 · PMID 36336278
60. Journal / agency Benowitz NL, Jacob P, Jones RT, Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. The Journal of Pharmacology and Experimental Therapeutics. May 1982. doi:10.1016/S0022-3565(25)33068-5 · PMID 7077531
61. Other Landoni JH. Nicotine (PIM)
62. Journal / agency Russell MA, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. British Medical Journal. April 1980. doi:10.1136/bmj.280.6219.972 · PMID 7417765 · PMC1601132
63. Journal / agency Bhalala O. Detection of Cotinine in Blood Plasma by HPLC MS/MS. MIT Undergraduate Research Journal. Spring 2003
64. Journal / agency Hukkanen J, Jacob P, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacological Reviews. March 2005. doi:10.1124/pr.57.1.3 · PMID 15734728
65. Journal / agency Petrick LM, Svidovsky A, Dubowski Y. Thirdhand smoke: heterogeneous oxidation of nicotine and secondary aerosol formation in the indoor environment. Environmental Science & Technology. January 2011. doi:10.1021/es102060v · PMID 21141815
66. Other The danger of third-hand smoke: Plain language summary. 22 February 2011
67. Journal / agency Benowitz NL, Herrera B, Jacob P. Mentholated cigarette smoking inhibits nicotine metabolism. The Journal of Pharmacology and Experimental Therapeutics. September 2004. doi:10.1124/jpet.104.066902 · PMID 15084646
68. Journal / agency Gholap VV, Kosmider L, Golshahi L, Halquist MS. Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?. Expert Opinion on Drug Delivery. December 2020. doi:10.1080/17425247.2020.1814736 · PMID 32842785 · PMC9361466
69. Journal / agency Duell AK, Pankow JF, Peyton DH. Nicotine in tobacco product aerosols: 'It's déjà vu all over again'. Tobacco Control. November 2020. doi:10.1136/tobaccocontrol-2019-055275 · PMID 31848312 · PMC7591799
70. Journal / agency Jenssen BP, Boykan R. Electronic Cigarettes and Youth in the United States: A Call to Action (at the Local, National and Global Levels). Children. February 2019. doi:10.3390/children6020030 · PMID 30791645 · PMC6406299
71. Journal / agency Frosina J, McEwan M, Ebajemito J, Thissen J, Taluskie K, Baxter-Wright S, Hardie G. Assessing the impact of protonating acid combinations in e-cigarette liquids: a randomised, crossover study on nicotine pharmacokinetics. Scientific Reports. June 2023. doi:10.1038/s41598-023-37539-6 · PMID 37386281 · PMC10310785
72. Journal / agency Nicotine' actions on energy balance: Friend or foe?. Pharmacology & Therapeutics. March 2021
73. Journal / agency Hu T, Yang Z, Li MD. Pharmacological Effects and Regulatory Mechanisms of Tobacco Smoking Effects on Food Intake and Weight Control. Journal of Neuroimmune Pharmacology. December 2018. doi:10.1007/s11481-018-9800-y · PMID 30054897
74. Journal / agency Picciotto MR, Mineur YS. Molecules and circuits involved in nicotine addiction: The many faces of smoking. Neuropharmacology. January 2014. doi:10.1016/j.neuropharm.2013.04.028 · PMID 23632083 · PMC3772953
75. Journal / agency Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine Psychopharmacology. 2009. doi:10.1007/978-3-540-69248-5_2 · PMID 19184645 · PMC2953858
76. Other Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. 2014
77. Journal / agency Mündel T, Jones DA. Effect of transdermal nicotine administration on exercise endurance in men. Experimental Physiology. July 2006. doi:10.1113/expphysiol.2006.033373 · PMID 16627574
78. Journal / agency Banala S, Arvin MC, Bannon NM, Jin XT, Macklin JJ, Wang Y, Peng C, Zhao G, Marshall JJ, Gee KR, Wokosin DL, Kim VJ, McIntosh JM, Contractor A, Lester HA, Kozorovitskiy Y, Drenan RM, Lavis LD. Photoactivatable drugs for nicotinic optopharmacology. Nature Methods. May 2018. doi:10.1038/nmeth.4637 · PMID 29578537 · PMC5923430

Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), Wikipedia (CC BY-SA 4.0), TripSit factsheets, PubChem (public domain). Each value links to the exact revision it came from.